Society News Archive
The U.S. Nuclear Regulatory Commission (NRC) is requesting information from the general public on a number of issues associated with medical treatment of patients with sodium iodide 131I (hereafter referred to as 131I). Specifically, the NRC would like input on patient concerns about medical treatment involving the use of 131I, information that physicians use to make decisions on when it is safe to release 131I patients based on radiation exposure concerns, radiation safety information used by 131I patients after their release, and the availability of a radiation safety informational guidance brochure for 131I patients that can be distributed nationwide. The information collected will be used to develop a website to provide patients with clear and consistent information about radioactive iodine treatments and to revise NRC patient release guidance.
Submit information and comments by 16 February 2016.